ZOGENIX INC's ticker is ZGNX and the CUSIP is 98978L204. A total of 158 filers reported holding ZOGENIX INC in Q1 2018. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $478,000 | -65.2% | 10,000 | -60.0% | 0.03% | -67.4% |
| Q1 2019 | $1,375,000 | -16.2% | 25,000 | -44.4% | 0.09% | -31.7% |
| Q4 2018 | $1,641,000 | -28.2% | 45,000 | -2.4% | 0.13% | 0.0% |
| Q3 2018 | $2,286,000 | +106.9% | 46,086 | +84.3% | 0.13% | +100.0% |
| Q2 2018 | $1,105,000 | -38.7% | 25,000 | -44.4% | 0.06% | -32.3% |
| Q1 2018 | $1,802,000 | -43.8% | 45,000 | -43.8% | 0.09% | -36.7% |
| Q4 2017 | $3,204,000 | -9.5% | 80,000 | -20.8% | 0.15% | -5.8% |
| Q3 2017 | $3,540,000 | – | 101,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 971,875 | $24,034,000 | 14.58% |
| Eversept Partners, LP | 2,013,467 | $49,793,039 | 12.38% |
| Pinz Capital Management, LP | 98,800 | $2,443,000 | 6.40% |
| RA Capital Management | 5,275,538 | $130,464,000 | 4.12% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,797 | $6,955,000 | 3.17% |
| Granite Point Capital Management, L.P. | 203,462 | $5,032,000 | 2.84% |
| Avoro Capital Advisors LLC | 2,800,000 | $69,244,000 | 2.34% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,029,699 | $25,464,000 | 2.33% |
| Eventide Asset Management | 2,841,300 | $70,265,000 | 2.28% |
| Perceptive Advisors | 3,452,921 | $85,390,000 | 2.22% |